Technology Offerings

New Drug Development for Transplantation and GvHD Using SLY-1 Inhibitor

The invention relates to a pharmaceutical composition comprising an inhibitor of SLY-1 (SH3 domain protein expressed in lymphocytes).

Further Information: PDF

Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000

Contact
Dr. Wolfgang Knappe

Comments (0)

Write a comment